Cefdin-TZ INJ 250/1000 reduces the development of drug-resistant bacteria and maintains the effectiveness. It is applicable in pneumonia, uncomplicated and complicated UTI, uncomplicated skin and skin structure infections, and complicated intra-abdominal infections. It is an empiric therapy for febrile neutropenic patients.